Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04767464 · ClinicalTrials.gov registry record · NA

Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups

A NA study of Breast Cancer and Breast Neoplasm, sponsored by Mary Radomski.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04767464: Completed NA study of Breast Cancer and Breast Neoplasm, sponsored by Mary Radomski.

NCT04767464 is a NA study of Breast Cancer and Breast Neoplasm that has completed, run by Mary Radomski. The registered enrollment target is 20 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04767464, a NA study of Breast Cancer and Breast Neoplasm, has completed, sponsored by Mary Radomski.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The Compass Course (CC) is a group intervention designed for individuals with Breast Cancer. Over the course of 8 face-to-face group sessions, the CC is designed to help participants reclaim a sense of self-grounded purpose in daily life, defined as intentional use of time and energy in ways that align with one's values, strengths, and sources of personal meaning (e.g., inner compass) in the moments that compose a day. Because of COVID-19, in-person groups are discouraged and so we need to identify new ways to provide group-based interventions that are feasible and efficacious.

Primary Outcome

A widely-used self-report questionnaire that was designed to measure 6 theoretically motivated dimensions of psychological well-being (autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, self-acceptance).

Interventions

  • OTHER Compass Course

Study Locations (1)

Minnesota

  • Abbott Northwestern Hospital - Minneapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-03-01
Est. Completion 2023-11-07
Phase NA
Mary Radomski

2 total trials

What the finished NCT04767464 record still lists

NCT04767464 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Compass Course is the first listed.

NCT04767464 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04767464 about?

NCT04767464 is a clinical study titled "Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups". The Compass Course (CC) is a group intervention designed for individuals with Breast Cancer. Over the course of 8 face-to-face group sessions, the CC is designed to help participants reclaim a sense of self-grounded purpose in daily life, defined as intentional use of time and energy in ways that al...

What is the current status of trial NCT04767464?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-03-01. Estimated completion is 2023-11-07.

What conditions does trial NCT04767464 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasm.

What interventions are being tested in trial NCT04767464?

The interventions under investigation include: Compass Course (OTHER).

Who is sponsoring clinical trial NCT04767464?

This trial is sponsored by Mary Radomski, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04767464 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04767464's enrollment target sits among peer trials

20 1079th of 1224 higher than 112 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04767464, the US trial registry maintained by the National Library of Medicine. NCT04767464 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.